Skip to main content
. 2022 Sep 20;12:951662. doi: 10.3389/fonc.2022.951662

Figure 2.

Figure 2

Local progression-free survival (LPFS) in the whole cohort of patients (A), in subgroups of primary and locally advanced cSCC (B) and in subgroups of naïve and pretreated patients (C).